Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.

Cited by papers we hold 6

• An Update on Self-Amplifying mRNA Vaccine Development · 2021
  No notice
• Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines · 2021
  No notice
• Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities · 2021
  No notice
• Advances in mRNA Vaccines for Infectious Diseases · 2019
  No notice
• New Vaccine Technologies to Combat Outbreak Situations · 2018
  No notice
• Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.